The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
312.00
+0.70 (0.22%)
At close: Apr 28, 2026
5.73%
Market Cap 9.73B
Revenue (ttm) 13.48B
Net Income (ttm) 788.34M
Shares Out 31.24M
EPS (ttm) n/a
PE Ratio 12.34
Forward PE n/a
Dividend 6.40 (2.06%)
Ex-Dividend Date Oct 27, 2025
Volume 21,918
Average Volume 21,521
Open n/a
Previous Close 311.30
Day's Range 301.00 - 314.70
52-Week Range 273.80 - 371.00
Beta 0.18
RSI 42.51
Earnings Date Apr 22, 2026

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Employees 5,200
Stock Exchange Dhaka Stock Exchange
Ticker Symbol IBNSINA
Full Company Profile

Financial Performance

In fiscal year 2025, DSE:IBNSINA's revenue was 11.88 billion, an increase of 4.51% compared to the previous year's 11.37 billion. Earnings were 633.19 million, a decrease of -5.57%.

Financial Statements

News

There is no news available yet.